Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis

Stolting, S., Klink, T., Bela, C., Engels, C., Wagner, T.

Int J Clin Pharmacol Ther. 2004 Nov;42(11):652-3.

http://www.ncbi.nlm.nih.gov/pubmed/15598036

Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis Read More »